We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:7949S Marchpole Holdings PLC 03 December 2003 3 December 2003 For immediate release Marchpole Holdings plc ("Marchpole" or the "Company") Vesting of share options At the AGM of the Company held at on 31 October 2002, shareholders approved the adoption of The Marchpole Holdings plc Enterprise Management Initiative Scheme (the "EMI Scheme"), a share option scheme established to incentivise the management of the Company. On 29 November 2002, Greg Tufnell and Justin Hampshire, directors of the Company, were awarded, subject to meeting performance criteria, 2,500,000 and 1,500,000 options under the EMI Scheme ("Options"). At the same time, a further 1,500,000 Options were awarded to employees of the Company under the EMI Scheme. The Options are over new ordinary shares of 1p each in the Company ("Shares"). The Remuneration Committee of the Company has now confirmed the award of the first tranche of one third of the Options, based on the performance criteria in respect of the twelve month period ended 29 November 2003. 833,333 and 500,000 Options have therefore vested with Greg Tufnell and Justin Hampshire respectively on 29 November 2003 and a further 87,000 Options have vested with other employees, each Option at a strike price of 4.75 pence per Share, all of which are exercisable immediately and for the period of ten years from the vesting date. The strike price was determined at the time of the Option grant by taking the average mid-market price for the three dealing days immediately preceding the date of grant. Accordingly, the interests in the Company of Greg Tufnell and Justin Hampshire are as follows: Shares Share held as % of Options issued share capital Greg Tufnell - - 833,333 Justin Hampshire 500,000 0.42% 500,000 Enquiries: Marchpole Holdings plc Justin Hampshire 020 7908 7777 Shore Capital Alex Borrelli / Simon Edwards 020 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange END RDSTJBLTMMBMMMJ
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions